In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project

By sjmartinez • September 19, 2024

Gong W, Yan Y, Liu J, Wang X, Zheng W, Que B, Ai H, Smith SC Jr, Fonarow GC, Morgan L, Zhao D, Ma C, Han Y, Nie S; CCC‐ACS Investigators. In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project. J Am Heart Assoc. 2024 Sep 18:e029252. doi: 10.1161/JAHA.122.029252. Epub ahead of print. PMID: 39291502.

Tags: acute coronary syndrome, Cardiology/Epi, guideline‐directed medical therapy, in‐hospital mortality, Publications, standard modifiable cardiovascular risk factors

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

Weiner AB, Agrawal R, Wang NK, Sonni I, Li EV, Arbet J, Zhang JJH, Proudfoot JA, Hong BH, Davicioni E, Kane N, Valle LF, Kishan[...]

Equity in Heart Failure Care: A Get With the Guidelines Analysis of Between- and Within-Hospital Differences in Care by Sex, Race, Ethnicity, and Insurance

Sandhu AT, Grau-Sepulveda MV, Witting C, Tisdale RL, Zheng J, Rodriguez F, Edward JA, Ambrosy AP, Greene SJ, Alhanti B, Fonarow GC, Joynt Maddox KE,[...]

Impact of Nonalcoholic Hepatic Steatosis on the Warranty Period of a Coronary Artery Calcium Score of 0: Results From the Multi-Ethnic Study of Atherosclerosis

Ichikawa K, Lim J, McClelland RL, Susarla S, Krishnan S, Benzing T, Kianoush S, Aldana-Bitar J, Manubolu VS, Budoff MJ. Impact of Nonalcoholic Hepatic Steatosis[...]